Physicians must evaluate the whole patient: medical history, risk factors, readiness for change, and long-term goals
When combined, patients may experience: Excessive appetite suppression , leading to inadequate caloric intake Unintended weight loss beyond therapeutic targets Nutritional deficiencies if dietary intake becomes severely restricted Difficulty maintaining energy for daily activities Hypoglycemia risk in patients also taking insulin or sulfonylureas, due to reduced food intake Gastrointestinal effects may also be compounded
Adjusting Injection Timing During Dose Escalation Most GLP-1 treatment plans begin with a low starting dose and increase gradually over 48 weeks to minimize side effects while your body adapts
The team included BBRF Scientific Council member Nora Volkow, M.D., a leading expert on addiction who is director of the NIHs National Institute on Drug Abuse (NIDA)
However, these same pharmacological actions may inadvertently influence sexual function through several pathways, though the evidence for specific mechanisms is variable and individual responses differ considerably
The Evolution of GLP-1 Medications Semaglutide originally gained fame as an injectable treatment for type 2 diabetes and later as a high-dose injection (Wegovy) for weight loss